Volume 21, Issue 126 (12-2014)
RJMS 2014, 21(126): 83-90 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Zabihiyeganeh M. Pregnancy and Rheumatic diseases. RJMS 2014; 21 (126) :83-90
URL: http://rjms.iums.ac.ir/article-1-3432-en.html
URL: http://rjms.iums.ac.ir/article-1-3432-en.html
Iran University of Medical Sciences, Tehran, Iran
Abstract: (6752 Views)
Pregnancy could be a challenge for physicians managing women with rheumatic diseases. Many of these diseases affect women of child-bearing age. Awareness of safe drugs, pregnancy effects on disease, and the effect of pregnancy are vitally important. For better results a group consisted of a gynecologist and internal physician should work together to these women. In general, active inflammation from rheumatic diseases immunosuppressant medications pose threat to health of both mother and fetus. In recent years availability of biologic therapies for treating resistant rheumatic diseases has created a great challenge concerning their safety during pregnancy and breastfeeding. During this study, we reviewed treatment of the most common rheumatic diseases including Rheumatoid Arthritis, Systemic Lupus Erythematous and Antiphospholipid syndrome. Prior, during and after pregnancy, the most relevant issues regarding medications will be discussed.
Type of Study: review article |
Subject:
Rheumatology
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
